Bone Marrow Scintigraphy as a Useful Method for Estimating the Physiological Status of Bone Marrow and Spleen in Polycythaemia Vera

References

• Najean Y., Arrago J. P., Rain J. D., Dresch C. The “Spent” phase of polycythaemia vera: hypersplenism in the absence of myelofibrosis. Br. J. Haematol. 1984; 56: 163–170
   PubMed Web of Science ®Google Scholar
• Najean Y., Caccione R., Castro-Malaspina H., Dresch C. Erythro kinetic studies in myelofibrosis: their singnificance for prognosis. Br. J. Haematol. 1978; 40: 205–217
   PubMed Web of Science ®Google Scholar
• Berlin N. I. Diagnosis and classification of the polycythemias. Semin. Hematol. 1975; 12: 339–351
   PubMed Web of Science ®Google Scholar
• Mac Neil B., Holman B. H., Button L. N., Rosenthal D. S. Use of indium chloride scintigraphys in patients with myelofibrosis. J. Nucl. Med. 1974; 15: 647–651
   PubMed Web of Science ®Google Scholar
• Najean Y., Legrand M., Poirier O., Senechal A., Arrago J. Clinical significance of serum procollagen III in chronic myeloproliferative disorders. Eur. J. Haematol. 1990; 45: 239–243
   PubMed Web of Science ®Google Scholar
• Parmentier C., Therain F., Charbord P., Aubert B., Morardet N. Comparative study of 111 In and 59 fe bone marrow scanning. Eur. J. Nucl. Med. 1977; 2: 89–92
   PubMedGoogle Scholar
• Chaudhuri T. K., Ehrhardt J. C., De Gowin R. L., Christie J. H. 59 Fe Whole body scanning. J. Nucl. Med. 1974; 15: 667–673
   PubMed Web of Science ®Google Scholar
• Ronai P., Winchell H. S., Auger H. O., Lawrence J. H. Whole body scanning of 59 Fe for evaluating body distribution of red cells and hepatic deposition of iron. J. Nucl. Med. 1969; 10: 469–474
   PubMed Web of Science ®Google Scholar
• Ferrant A., Rodhain J., Cauwe F., Beckers C., Michaux J. L., Verwilgren R., Sokal G. Assessment of bone marrow and splenic erythropoiesis in myelofibrosis. Scand. J. Haematol. 1982; 29: 373–380
   PubMedGoogle Scholar
• Beamish M. R., Brown E. B. The metabolism of transferrin-bound 111 In and 59 Fe in the rat. Blood 1974; 43: 693–701
   PubMed Web of Science ®Google Scholar
• Mc Intyre P. A., Larson B. M., Eikman E. A., Colman M., Scheffel V., Hodkinson B. A. Comparison of the metabolism of iron labeled-transferrin (Fe-Tf) and Indium-labeled transferrin (In-Tf) by the erythopoietic marrow. J. Nucl. Med. 1974; 15: 856–862
   PubMed Web of Science ®Google Scholar
• Merrick M. V., Gordon-Smith E. C., Lavender J. P., Szur L. A comparison of 111 In with 59 Fe and 99 mTc-Sulfur colloid for bone marrow scanning. J. Nucl. Med. 1975; 16: 66–68
   PubMed Web of Science ®Google Scholar
• Arrago J. P., Rain J. D., Vigneron N., Poirier O., Chomienne C., D'Agay M. F., Najean Y. Diagnostic value of bone marrow imaging with 111 Indium-Tranferrin and 99m Tech-netium-Colloïds in myelofibrosis. Am. J. Hematol. 1985; 18: 275–282
   PubMed Web of Science ®Google Scholar
• Rain J. D., Najean Y. Bone marrow scintigraphy in myelofibrosis. Nouv. Rev. Fr. Hematol. 1993; 35: 101–102
   PubMedGoogle Scholar
• Sayle B. A., Helmer R. E., Birdsong B. A., Balachandran S., Gardner F. H. Bone marrow imaging with Indium 111 chloride in aplastic anemia and myelofibrosis: concise communication. J. Nucl. Med. 1982; 121–125
   PubMed Web of Science ®Google Scholar
• Datz F. L., Taylor A. The clinical use of radionuclide bone marrow imaging. Semin. Nucl. Med. 1985; 15: 239–259
   PubMed Web of Science ®Google Scholar
• Harnsberger H. R., Datz F. L., Knochel J. Q. Failure to detect extra medullary hematopoiesis during bone marrow imaging with Indium 111 or Technetium 99 m Sulfur colloïd. J. Nucl. Med. 1982; 23: 589–590
   PubMed Web of Science ®Google Scholar
• Vieras F. Splenic uptake of In 111. J. Nucl. Med. 1975; 16: 1205–1206
   PubMed Web of Science ®Google Scholar
• Staub R. T., Gaston E. In 111 Chloride distribution and kinetics in hematologic disease. J. Nucl. Med. 1973; 14: 456–457
   Web of Science ®Google Scholar
• Ward H. P., Block M. H. The natural history of agno-genic myeloid metaplasia (A.M.M) and a critical evaluation of its relationship with the myeloproliferative syndrome. Medecine 1971; 50: 357–420
   Google Scholar
• Van Dyke B., Shkurkin C., Price D., Yano Y., Auger H. O. Differences in distribution of erythropoietic and reticulo endothelial marrow in hematological disease. Blood 1967; 30: 364–374
   PubMed Web of Science ®Google Scholar
• Ferrant A., Rodhain J., Leners N. Quantitative assessment of erythropoiesis in bone marrow expansion areas using 52 Fe. Br. J. Haematol. 1986; 62: 247–255
   PubMed Web of Science ®Google Scholar
• Rain J. D., Najean Y. Scintigraphie medullaire. Apport pour le diagnostic et le pronostic des myelofibroses. Presse Médicale 1993; 22: 855–863
   PubMedGoogle Scholar
• Schlageter M. H., Toubert M. E., Podgorniak M. P., Najean Y. Radio-immuno assay of erythropoietin: analytical performance and clinical use in hematology. Clin. Chem. 1990; 36: 1731–1735
   PubMed Web of Science ®Google Scholar
• Barosi G., Ambrosetti A., Buratti A., Finelli C., Liberate N. L., Quaglini S., Ricetti M. M., Visani G., Tura S., Ascari E. Splenectomy for patients with myelofibrosis with myeloid metaplasia: pretreatment variables and outcome prediction. Leukemia 1993; 7: 200–206
   PubMed Web of Science ®Google Scholar